Cipla Ltd. — Regulatory Filings 2021

Dec 14, 2021

==> picture [84 x 30] intentionally omitted <==

14[th] December 2021

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA EQ

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

- Sub: Dissolution of Step Down Wholly Owned Subsidiary

This is to inform you that Inyanga Trading 386 (Pty) Limited (“Inyanga”), wholly owned subsidiary of Cipla Medpro South Africa (Pty) Limited and a wholly owned step-down subsidiary of the Company, has been dissolved with effect from 10[th] December 2021. Inyanga was a dormant entity and this dissolution will not affect performance or revenue of the Company.

This is for your information and records.

Thanking you

Yours faithfully,

For Cipla Limited

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2021.12.14 CHOPRA 18:41:16 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Mandar Kurghode

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 24826000 F +91 22 24826120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380